Gamma Medica Inc is categorized under Commercial Medical Research in Salem, NH and active since 2013.
Gamma Medica Inc was established in 2013, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact David Eichler at the company’s single location by writing to 12 Manor Parkway # 3, Salem, New Hampshire NH 03079 or by phoning (603) 952-4441. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Gamma Medica Inc |
| Contact Person: | David Eichler |
| Address: | 12 Manor Parkway # 3, Salem, New Hampshire 03079 |
| Phone Number: | (603) 952-4441 |
| Website Address: | psilos.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Gamma Medica Inc was started in 2013 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact David Eichler for inquiries that concern Gamma Medica Inc by calling the company number (603) 952-4441, as your correspondence is most welcome. Additionally, the physical location of the single location of Gamma Medica Inc can be found at the coordinates 42.780016,-71.250896 as well as the street address 12 Manor Parkway # 3 in Salem, New Hampshire 03079.
For its online presence, you may visit Gamma Medica Inc’s website at psilos.com and engage with its social media outlets through on Twitter and on Facebook.